首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations
【24h】

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations

机译:None

获取原文
获取原文并翻译 | 示例
           

摘要

The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. Although this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state-of-the-art treatments, including transplantation, by providing financial, technological, legal, ethical, and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population and potentially provide long-term cost savings by circumventing the need for their citizens to seek care abroad. The costs of establishing an HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. In addition, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT, and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation for establishing HSCT programs, with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in resource-constrained settings. (C) 2019 The Author(s). Published by Elsevier Ltd. on behalf of King Faisal Specialist Hospital & Research Centre and Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.
机译:造血干细胞移植(HSCT)计划的发展可能面临大多数发展中国家的重大挑战,因为这种努力必须与其他政府保健优先事项竞争,包括提供基本服务。虽然这可能是一个限制因素,但这些国家应优先考虑所需专业知识,以提供最先进的治疗,包括移植,通过提供财务,技术,法律,道德和其他所需的支持。这将使这将有利于提供定制于他们人口需求的成功计划,并可能通过避免其公民在国外寻求护理的需求来提供长期成本节约。建立机规律计划的成本和HSCT程序本身的成本可能是发展中国家的主要障碍。此外,特定国家的社会经济因素的内在可以影响HSCT,HSCT的耐心资格,以及及时利用HSCT中心功能。本报告介绍了全球血液和骨髓移植网络的建议,以确定HSCT计划,并在发展中国家的特定关注,并确定在资源受限环境中提供此专业程序的挑战和机遇。 (c)2019年作者。由elsevier有限公司发表代表国王费萨尔专家医院和研究中心和elsevier Inc.代表美国移植和细胞疗法。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号